Quit and Screen Project

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-85
SponsorUniversity of Arkansas

About this trial

The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.

The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Eligibility criteria

Qualifiers

Current National Medical Association (NMA) member

Serves a patient clientele who smokes

At least 20% of time (1 day per week) devoted to clinical care

Currently screens clients for tobacco use in the clinic

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Quit and Screen Project training
  • G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Arkansas

Lead sponsor

Virginia Commonwealth University

Collaborator

Coalition for a Tobacco Free Arkansas

Collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

National Medical Association

Collaborator